

|
Using clever chemistry, a Scripps Research team has pinpointed the enzyme target of a drug group that stops the progression of the devastating disease Friedreich's ataxia in mice and may do the same for humans.
|
|
Repligen Corporation reported publication of research that identifies histone deacetylase 3 as an important enzyme target for therapeutic intervention in Friedreich's ataxia.
|